Ian Arroyo - 18 Mar 2026 Form 3 Insider Report for Freightos Ltd (CRGO)

Role
Chief Strategy Officer
Signature
/s/ Michael Oberlander, attorney-in-fact
Issuer symbol
CRGO
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 12:31:13 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Arroyo Ian Chief Strategy Officer C/O FREIGHTOS LIMITED, PLANTA 10, AVDA. DIAGONAL, 211, BARCELONA, SPAIN /s/ Michael Oberlander, attorney-in-fact 18 Mar 2026 0001976393

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRGO Ordinary shares 21,141 18 Mar 2026 Direct
holding CRGO Ordinary shares 37,500 18 Mar 2026 Direct F1
holding CRGO Ordinary shares 37,500 18 Mar 2026 Direct F2
holding CRGO Ordinary shares 36,000 18 Mar 2026 Direct F3
holding CRGO Ordinary shares 7,000 18 Mar 2026 Direct F4
holding CRGO Ordinary shares 21,500 18 Mar 2026 Direct F5
holding CRGO Ordinary shares 38,000 18 Mar 2026 Direct F6
holding CRGO Ordinary shares 38,000 18 Mar 2026 Direct F7
holding CRGO Ordinary shares 54,600 18 Mar 2026 Direct F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CRGO Stock options (right to buy) 18 Mar 2026 Ordinary shares 49,473 $1.07 Direct
holding CRGO Stock options (right to buy) 18 Mar 2026 Ordinary shares 12,314 $4.17 Direct
holding CRGO Stock options (right to buy) 18 Mar 2026 Ordinary shares 228,674 $4.17 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2027.
F2 The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on July 15, 2026.
F3 The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on July 1, 2025 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: 33.33% of the RSUs vest upon the one-year anniversary of the vesting commencement date, and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs will be vested by the three-year anniversary of the vesting commencement date.
F4 The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) on an equal, quarterly basis (33.33% per quarter) such that all such RSUs will be vested by July 15, 2026.
F5 The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) on an equal, quarterly basis (approximately 14.286% per quarter) such that all such RSUs will be vested by July 15, 2027.
F6 The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2026.
F7 The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2027.
F8 The options reported in this row vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 50% of the options vest on the one-year anniversary of the vesting commencement date (March 16, 2027) and the remaining 50% of the options vest on the two-year anniversary of the vesting commencement date (March 16, 2028).

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney.